| Literature DB >> 35283967 |
Nahyan Almansoori1, Nivisha Parag1.
Abstract
Background: Antibiotic resistance is a major public health concern. The Emergency department (ED) is the community gate for healthcare where antibiotics are often prescribed. However, there is a paucity of data regarding antibiotic prescription practices in Africa.Entities:
Keywords: Antimicrobial resistance; antibiotic stewardship; emergency department
Mesh:
Substances:
Year: 2021 PMID: 35283967 PMCID: PMC8889821 DOI: 10.4314/ahs.v21i4.19
Source DB: PubMed Journal: Afr Health Sci ISSN: 1680-6905 Impact factor: 0.927
Age distribution and female to male ratio for patients received anti-microbial therapy
| Age group | Distribution | Female | Male | Total |
|
| 0.1 – 5 years | 1 | 5 | 6 |
|
| 6 – 10 years | 4 | 8 | 12 |
|
| 11 – 19 years | 6 | 8 | 14 |
|
| 20 – 29 years | 22 | 36 | 58 |
|
| 30 – 39 years | 15 | 20 | 35 |
|
| 40 – 49 years | 11 | 18 | 29 |
|
| 50 – 59 years | 10 | 11 | 21 |
|
| 60 – 69 years | 8 | 5 | 13 |
|
| 70 – 104 years | 3 | 4 | 7 |
|
| 80 | 115 | 195 |
Indications for antibiotics
| Diagnosis | Frequency | Percentage |
| Abscess | 37 | 18.97% |
| Appendicitis | 18 | 9.2% |
| Cellulitis | 17 | 8.71 |
| Tonsillitis | 7 | 3.58% |
| Septic Wound | 6 | 3.07% |
| UTI | 5 | 2.56% |
| Acute Cholecystitis / | 4 | 2.05 |
| UGIB | 2 | 1.02% |
| Gangrene | 2 | 1.02% |
| Sepsis / infection | 21 | 10.7% |
| LRTI | 14 | 7.17% |
| Post TB Bronchiectasis | 4 | 2.05% |
| AGE | 4 | 2.05% |
| Hypoglycemia | 3 | 1.53% |
| Meningitis | 3 | 1.53% |
| DKA secondary to infection | 3 | 1.53% |
| Asthma / COPD | 2 | 1.02% |
| Injury | 13 | 6.66% |
| GSW | 8 | 4.1% |
| MVA | 4 | 2.05% |
| Fracture | 9 | 4.6% |
| Septic arthritis | 4 | 2.05% |
| PID | 3 | 1.53% |
| PEP | 1 | 0.51% |
| Abdominal Distension | 1 | 0.51% |
|
| 195 | 100% |
Graph 1Prescriber distribution at ED
Graph 2Administration Route
Anti-microbial agents prescribed at E.D
| Antibiotics | Freq. | Percent |
| Ampicillin | 1 | 0.51 |
| Ampicillin + Ceftriaxone | 1 | 0.51 |
| Augmentin | 138 | 70.77 |
| Augmentin + Azithromycin | 15 | 7.69 |
| Augmentin + Azithromycin +ceftriaxone | 1 | 0.51 |
| Augmentin + Metronidazole | 2 | 1.03 |
| Augmentin + Metronidazole + | 1 | 0.51 |
| Augmentin + acyclovir + fluconazole | 1 | 0.51 |
| Azithromycin | 2 | 1.03 |
| Cefazolin | 7 | 3.59 |
| Ceftriaxone | 13 | 6.67 |
| Ceftriaxone + Azithromycin | 2 | 1.03 |
| Ciprofloxacillin | 1 | 0.51 |
| Cloxacillin | 6 | 3.08 |
| Cloxacillin + floxacillin 1 g QID | 1 | 0.51 |
| Floxacillin | 1 | 0.51 |
| Metronidazole | 1 | 0.51 |
| Tazocin + clindamycin | 1 | 0.51 |
|
| 195 | 100 |
Correct choice at time of prescription in comparison to EDL 2015 hospital level
| Correct choice | Female | Male | p-value |
|
| 35 | 55 | 0.654 |
|
| 40 | 54 | |
|
| 5 | 6 | 1.000 |
|
| 80 | 115 |
Correct dosage at time of prescription in comparison to EDL 2015 hospital level
| Correct dose | Female | Male | p-value |
|
| 74 | 107 | 1.000 |
|
| 6 | 8 | |
|
| 80 | 115 |